Mylan gets South Africa contract for HIV meds; India's SRF buys DuPont's pharma propellant business;

> Mylan ($MYL) says its South Africa unit has gotten a three-year contract from the government there to manufacture antiretroviral (ARV) drugs for the country's treatment program. Release

> Baxter Healthcare ($BAX) is recalling 7,220 bags of an injectable product because of leaking bags. Recall

> Zydus Pharmaceuticals is recalling nearly 59,000 bottles of benzonatate, manufactured by its Cadila Healthcare operation Ahmedabad, India, because of leaking capsules. Recall

> American Health Packaging is recalling 3496 cartons of mercaptopurine tablets manufactured by San Diego, CA-based Prometheus Laboratories because the tablets failed dissolution tests. Recall

> Italian Medicines Agency pulls GMP certificate from Indian firm. Report

> India's SRF has acquired DuPont's ($DD) Dymel pharmaceutical propellant business for $20 million. Report

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.